Antimicrobial Efficacy of Intracanal Medicaments Incorporated With Nanoparticles in Primary Teeth: An In Vitro Study
- PMID: 40524740
- PMCID: PMC12170068
- DOI: 10.1155/tswj/5182716
Antimicrobial Efficacy of Intracanal Medicaments Incorporated With Nanoparticles in Primary Teeth: An In Vitro Study
Abstract
Placing an intracanal medicament helps in the disinfection of primary root canals, and nanoparticles enhance the material properties by increasing the physical and chemical reactivity. The study was aimed at assessing the efficacy of calcium hydroxide+calcium hydroxide nanoparticles and zinc oxide+zinc oxide nanoparticles as an intracanal medicament when compared with calcium hydroxide and zinc oxide eugenol in terms of antibacterial efficacy and penetration depth. Forty extracted human primary teeth were included in the study. Of these, 40 teeth were divided into two subgroups-Group A (to assess antibacterial efficacy) and Group B (to assess penetration depth). The teeth in Group A were contaminated with an Enterococcus faecalis biofilm for 7 days, and CFU count was determined. Calcium hydroxide (A1), calcium hydroxide with calcium hydroxide nanoparticles (A2), zinc oxide with zinc oxide nanoparticles (A3), and zinc oxide eugenol (A4) were placed in the canals. CFU count was determined on Day 7 and Day 14. The teeth in Group B were also divided into calcium hydroxide (B1), calcium hydroxide with calcium hydroxide nanoparticles (B2), zinc oxide with zinc oxide nanoparticles (B3), and zinc oxide eugenol (B4) groups. Two teeth from each group were subjected to SEM analysis. A statistically significant difference was noted in the CFU count reduction on Day 7 in Group A2, Group A3, and Group A4. The highest penetration depth was noted in Group B2. The authors concluded that the antibacterial efficacy and penetration depth into dentin improved on incorporating calcium hydroxide and zinc oxide nanoparticles. Based on this conclusion, the authors recommend further in vivo studies with nanoparticles incorporated intracanal medicaments in primary teeth to determine their safety of use and feasibility in a clinical scenario.
Copyright © 2025 Azra Kaukab and Sridhar Nekkanti. The Scientific World Journal published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Pulp treatment for extensive decay in primary teeth.Cochrane Database Syst Rev. 2018 May 31;5(5):CD003220. doi: 10.1002/14651858.CD003220.pub3. Cochrane Database Syst Rev. 2018. PMID: 29852056 Free PMC article.
-
Pulp treatment for extensive decay in primary teeth.Cochrane Database Syst Rev. 2014 Aug 6;(8):CD003220. doi: 10.1002/14651858.CD003220.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2018 May 31;5:CD003220. doi: 10.1002/14651858.CD003220.pub3. PMID: 25099759 Updated.
-
Efficacy of chitosan root canal medicament against cross-kingdom dual-species biofilm of Candida albicans and Enterococcus faecalis in an in vitro root-canal model.Odontology. 2025 Jul;113(3):956-964. doi: 10.1007/s10266-024-01024-x. Epub 2024 Nov 14. Odontology. 2025. PMID: 39540969
-
Tooth discoloration caused by nanographene oxide as an irrigant and intracanal medicament in the endodontic treatment of extracted single-rooted teeth: An ex-vivo study.PLoS One. 2025 Jun 26;20(6):e0325430. doi: 10.1371/journal.pone.0325430. eCollection 2025. PLoS One. 2025. PMID: 40569948 Free PMC article.
-
Calcium hydroxide-loaded nanoparticles dispersed in thermosensitive gel as a novel intracanal medicament.Int Endod J. 2024 Jul;57(7):907-921. doi: 10.1111/iej.14041. Epub 2024 Feb 19. Int Endod J. 2024. PMID: 38374518
References
-
- American Academy of Pediatric Dentistry. Pulp Therapy for Primary and Immature Permanent Teeth. The Reference Manual of Pediatric Dentistry . American Academy of Pediatric Dentistry; 2021.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources